Infectious Disease· Topic 7.17 Specific causative organisms· 7.17.15

Measles

Measles (rubeola) is a highly contagious paramyxovirus infection that has re-emerged in the United States because of low vaccination rates, presenting with a prodrome of the 4 C's followed by a cephalocaudal maculopapular rash, confirmed by PCR or IgM, and managed with supportive care plus vitamin A.

8 min read8 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Highly contagious paramyxovirus infection: measles presents with high fever, rhinorrhea, cough, conjunctivitis, Koplik spots, and a diffuse macular rash.

  • Epidemiology

    Resurgence tied to vaccination gaps: measles had been eliminated in the United States in 2000; re-emergence is driven by low vaccination rates in the population combined with reintroduction of the virus from endemic countries.

  • Risk factors

    Lack of measles-mumps-rubella (MMR) vaccination or unknown vaccination status, particularly in adults born in 1957 or later.

  • Pathophysiology

    Respiratory transmission of a highly contagious paramyxovirus establishes infection of the respiratory epithelium before systemic spread, producing the prodromal fever, cough, coryza, and conjunctivitis.

  • Clinical features

    Prodrome of the 4 C's: cough, coryza, conjunctivitis, and Coplik spots, together with high fever, precede the rash and together establish the clinical pattern of measles.

  • Differential diagnosis

    Rubella: a fainter maculopapular rash than measles that does not coalesce, beginning on the face and neck and spreading to the trunk and extremities over 1 to 2 days, with an evanescent quality that…

  • Diagnosis

    Measles is confirmed by real-time polymerase chain reaction (PCR) detection of viral RNA in respiratory and urine samples or by measles-specific IgM in serum; when the classic prodrome (the 4 C's)…

  • Management

    Measles is brief and self-limited for most children, and treatment is supportive: there is no specific antiviral therapy directed at the measles virus; management centers on monitoring for and treating complications.

  • Complications

    Otitis media, the most common complication of measles.

  • Prognosis

    Self-limited course in most children, with brief illness and supportive treatment sufficient for recovery.

  • Prevention

    Two-dose measles-mumps-rubella (MMR) live-attenuated vaccine is the best way to prevent infection, given at 12-15 months and again at 4-6 years of age in the routine pediatric schedule.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.